Swallow this pill: new capsule could spot internal bleeding instantly

NCT ID NCT06715293

Recruiting now Diagnosis Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a wireless capsule called Hemopill that patients swallow to detect active bleeding in the upper digestive tract. Researchers will compare its accuracy to standard endoscopy in 193 people with signs of bleeding. If it works, the capsule could help doctors quickly decide who needs emergency treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Hemopill (wireless optical sensor capsule)
What this could lead to: If successful, this capsule could provide a fast, non-invasive way to detect upper GI bleeding, helping doctors decide who needs urgent endoscopy and who can wait.
What could go wrong: This is an early-stage study with only 193 participants. The capsule may not detect all bleeding types, and results need confirmation in larger, more diverse groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL BLEEDING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Gastrointestinal Hemorrhage Hematemesis Melena

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTROINTESTINAL BLEEDING HEMATEMESIS MELENA

Contacts and locations

Locations

Prince of Wales Hospital
RECRUITING

Shatin, Hong Kong Island, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.